(NASDAQ: EYEN) (“Eyenovia” or the “Company”), an ophthalmic technology company focused on completing development of its proprietary Optejet topical ophthalmic medication dispensing platform, today ...
Advanced Micro Devices (AMD -6.37%) has been a top performer in the semiconductor industry over the last decade. The fabless chip stock has grabbed market share from Intel PCs and ...
ONTARIO, CA / ACCESS Newswire / January 29, 2025 / Focus Universal inc. (Nasdaq:FCUV) ("Focus" or the "Company"), a provider ...
Enveric Biosciences Inc. (NASDAQ:ENVB), a pharmaceutical preparations company with a market capitalization of $3.43 million, ...
Hosted on MSN1d
REVB Start 1B Trial and Announces SplitREVB READ THE FULL REVB RESEARCH REPORT Revelation Biosciences (NASDAQ:REVB) announced that it has initiated its US based Phase 1b clinical study to evaluate the potential of Gemini as a ...
The company has already cut its workforce, seen a leadership change and agreed to be acquired. Here's what's next.
Global Interactive Technologies, Inc. (Nasdaq: GITS) filed a Form 8-K with the Securities and Exchange Commission, disclosing its intent to carry out a 1-for-20 reverse stock split of its issued and ...
ZK International Group (ZKIN) announces 1-for-7 reverse stock split to meet NASDAQ listing requirements, effective Jan.
Stock splits don't create any inherent value ... He anticipates speedy sales growth for Alzheimer's disease treatment Kisunla. CFRA has a "buy" rating and $1,085 price target for LLY stock.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback